Copyright Reports & Markets. All rights reserved.

Global Injectable Nanomedicines Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Injectable Nanomedicines Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Liposomes
      • 1.4.3 Micelles
      • 1.4.4 Nanocrystals
      • 1.4.5 Others
    • 1.5 Market by Application
      • 1.5.1 Global Injectable Nanomedicines Market Share by Application (2014-2025)
      • 1.5.2 Hospitals
      • 1.5.3 Clinics
      • 1.5.4 Ambulatory Surgical Centers
      • 1.5.5 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Injectable Nanomedicines Market Size
    • 2.2 Injectable Nanomedicines Growth Trends by Regions
      • 2.2.1 Injectable Nanomedicines Market Size by Regions (2014-2025)
      • 2.2.2 Injectable Nanomedicines Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Injectable Nanomedicines Market Size by Manufacturers
      • 3.1.1 Global Injectable Nanomedicines Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Injectable Nanomedicines Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Injectable Nanomedicines Market Concentration Ratio (CR5 and HHI)
    • 3.2 Injectable Nanomedicines Key Players Head office and Area Served
    • 3.3 Key Players Injectable Nanomedicines Product/Solution/Service
    • 3.4 Date of Enter into Injectable Nanomedicines Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Injectable Nanomedicines Market Size by Type (2014-2019)
    • 4.2 Global Injectable Nanomedicines Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Injectable Nanomedicines Market Size (2014-2019)
    • 5.2 Injectable Nanomedicines Key Players in United States
    • 5.3 United States Injectable Nanomedicines Market Size by Type
    • 5.4 United States Injectable Nanomedicines Market Size by Application

    6 Europe

    • 6.1 Europe Injectable Nanomedicines Market Size (2014-2019)
    • 6.2 Injectable Nanomedicines Key Players in Europe
    • 6.3 Europe Injectable Nanomedicines Market Size by Type
    • 6.4 Europe Injectable Nanomedicines Market Size by Application

    7 China

    • 7.1 China Injectable Nanomedicines Market Size (2014-2019)
    • 7.2 Injectable Nanomedicines Key Players in China
    • 7.3 China Injectable Nanomedicines Market Size by Type
    • 7.4 China Injectable Nanomedicines Market Size by Application

    8 Japan

    • 8.1 Japan Injectable Nanomedicines Market Size (2014-2019)
    • 8.2 Injectable Nanomedicines Key Players in Japan
    • 8.3 Japan Injectable Nanomedicines Market Size by Type
    • 8.4 Japan Injectable Nanomedicines Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Injectable Nanomedicines Market Size (2014-2019)
    • 9.2 Injectable Nanomedicines Key Players in Southeast Asia
    • 9.3 Southeast Asia Injectable Nanomedicines Market Size by Type
    • 9.4 Southeast Asia Injectable Nanomedicines Market Size by Application

    10 India

    • 10.1 India Injectable Nanomedicines Market Size (2014-2019)
    • 10.2 Injectable Nanomedicines Key Players in India
    • 10.3 India Injectable Nanomedicines Market Size by Type
    • 10.4 India Injectable Nanomedicines Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Injectable Nanomedicines Market Size (2014-2019)
    • 11.2 Injectable Nanomedicines Key Players in Central & South America
    • 11.3 Central & South America Injectable Nanomedicines Market Size by Type
    • 11.4 Central & South America Injectable Nanomedicines Market Size by Application

    12 International Players Profiles

    • 12.1 Pfizer
      • 12.1.1 Pfizer Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Injectable Nanomedicines Introduction
      • 12.1.4 Pfizer Revenue in Injectable Nanomedicines Business (2014-2019)
      • 12.1.5 Pfizer Recent Development
    • 12.2 Johnson & Johnson
      • 12.2.1 Johnson & Johnson Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Injectable Nanomedicines Introduction
      • 12.2.4 Johnson & Johnson Revenue in Injectable Nanomedicines Business (2014-2019)
      • 12.2.5 Johnson & Johnson Recent Development
    • 12.3 Merck
      • 12.3.1 Merck Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Injectable Nanomedicines Introduction
      • 12.3.4 Merck Revenue in Injectable Nanomedicines Business (2014-2019)
      • 12.3.5 Merck Recent Development
    • 12.4 Roche
      • 12.4.1 Roche Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Injectable Nanomedicines Introduction
      • 12.4.4 Roche Revenue in Injectable Nanomedicines Business (2014-2019)
      • 12.4.5 Roche Recent Development
    • 12.5 Lupin
      • 12.5.1 Lupin Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Injectable Nanomedicines Introduction
      • 12.5.4 Lupin Revenue in Injectable Nanomedicines Business (2014-2019)
      • 12.5.5 Lupin Recent Development
    • 12.6 Teva Pharmaceutical
      • 12.6.1 Teva Pharmaceutical Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Injectable Nanomedicines Introduction
      • 12.6.4 Teva Pharmaceutical Revenue in Injectable Nanomedicines Business (2014-2019)
      • 12.6.5 Teva Pharmaceutical Recent Development
    • 12.7 Bausch Health
      • 12.7.1 Bausch Health Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Injectable Nanomedicines Introduction
      • 12.7.4 Bausch Health Revenue in Injectable Nanomedicines Business (2014-2019)
      • 12.7.5 Bausch Health Recent Development
    • 12.8 Celgene
      • 12.8.1 Celgene Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Injectable Nanomedicines Introduction
      • 12.8.4 Celgene Revenue in Injectable Nanomedicines Business (2014-2019)
      • 12.8.5 Celgene Recent Development
    • 12.9 Amgen
      • 12.9.1 Amgen Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Injectable Nanomedicines Introduction
      • 12.9.4 Amgen Revenue in Injectable Nanomedicines Business (2014-2019)
      • 12.9.5 Amgen Recent Development
    • 12.10 Pacira Pharmaceuticals
      • 12.10.1 Pacira Pharmaceuticals Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Injectable Nanomedicines Introduction
      • 12.10.4 Pacira Pharmaceuticals Revenue in Injectable Nanomedicines Business (2014-2019)
      • 12.10.5 Pacira Pharmaceuticals Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      In 2018, the global Injectable Nanomedicines market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Injectable Nanomedicines status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Injectable Nanomedicines development in United States, Europe and China.

      The key players covered in this study
      Pfizer
      Johnson & Johnson
      Merck
      Roche
      Lupin
      Teva Pharmaceutical
      Bausch Health
      Celgene
      Amgen
      Pacira Pharmaceuticals

      Market segment by Type, the product can be split into
      Liposomes
      Micelles
      Nanocrystals
      Others

      Market segment by Application, split into
      Hospitals
      Clinics
      Ambulatory Surgical Centers
      Others

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Injectable Nanomedicines status, future forecast, growth opportunity, key market and key players.
      To present the Injectable Nanomedicines development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Injectable Nanomedicines are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now